S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7127 +0.25%
CLOSED · 23:25 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
LN
INSIDER · ANIP · ANI PHARMACEUTICALS INC · PRESIDENT & CEO

Lalwani Nikhil

Every open-market transaction filed under this name, Aug 25 to Oct 15.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$1.2M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 15ANIPANI PHARMACEUTICALS INCPRESIDENT & CEOSell5,400$71.89$388K+0.5%
Sep 15ANIPANI PHARMACEUTICALS INCPRESIDENT & CEOSell5,400$71.00$383K+1.7%
Aug 25ANIPANI PHARMACEUTICALS INCPRESIDENT & CEOSell5,400$74.30$401K−2.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.